Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.5.1.20 (
methylenetetrahydrofolate reductase
)
2,134
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Osteoarthritis
is a degenerative joint disorder resulting in destruction of articular cartilage, osteophyte formation, and subchondral bone sclerosis. In recent years, numerous genetic factors have been identified and implicated in
osteoarthritis
. The aim of the current study was to examine the influence of
methylenetetrahydrofolate reductase
(
MTHFR
) gene C677T mutation and angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) variations on the risk of
osteoarthritis
. Genomic DNA is obtained from 421 persons (221 patients with
osteoarthritis
and 200 healthy controls). ACE gene I/D polymorphism genotypes were determined using polymerase chain reaction using I and D allele-specific primers. The
MTHFR
C677T mutation was analyzed by polymerase chain reaction (PCR) based restriction fragment length polymorphism (RFLP) methods. We found significant difference between the groups with respect to both ACE and
MTHFR
genotype distributions (p< 0.001, p< 0.001 respectively). Our study suggests that ACE gene DD genotype and
MTHFR
gene CC genotype could be used as genetic markers in
osteoarthritis
in Turkish study populations.
...
PMID:MTHFR gene C677T mutation and ACE gene I/D polymorphism in Turkish patients with osteoarthritis. 2308 24